Back
Speaker illustration

undefined undefined undefined

Presentations

Prognostic role of sarcopenia and effect of SGLT2-inhibitors on MACE in heart failure patients

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, prognosis, and outcome in chronic heart failure (1)

Access
Like
Thumbnail

Role of Vericiguat on clinical, echocardiographic and comprehensive geriatric assessment parameters in elderly patients with worsening Heart Failure

Event: Heart Failure 2025

Topic: Multidisciplinary Interventions

Session: Updates in advanced and acute heart failure

Access
Like
Thumbnail

Impact of ferric carboxymaltose therapy on renal function in patients with chronic heart failure and anemia

Event: Heart Failure 2025

Topic: Comorbidities

Session: Complex comorbidities and heart failure

Access
Like
Thumbnail

Effect of oral semaglutide on global longitudinal strain and global myocardial work efficiency in patients with HFpEF, uncontrolled type 2 diabetes mellitus and obesity.

Event: Heart Failure 2024

Topic: Comorbidities

Session: Chronic heart failure - comorbidities 2

Access
Like
Thumbnail

Prognostic role of serum albumin levels in patients with chronic heart failure.

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Acute heart failure - epidemiology, prognosis, outcome 2

Access
Like
Thumbnail

Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.

Event: Heart Failure 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure - pathophysiology and mechanisms 2

Access
Like
Thumbnail

Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Cardiovascular Disease in the Elderly

Session: Heart disease in the elderly: treatment and outcomes

Access
Like
Thumbnail

Effect of semaglutide on global longitudinal strain and global myocardial work efficiency in patients with uncontrolled type 2 diabetes mellitus and obesity.

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Diabetes and the heart (3)

Access
Like
Thumbnail

Short term effect of sodium glucose cotransporter 2 inhibitors and sacubitril/valsartan on comprehensive geriatric assessment and oxidative stress in elderly with chronic heart failure (from MAGIC-HF)

Event: ESC Congress 2023

Topic: Comorbidities

Session: Comorbidities and heart failure: cause and effect

Access
Like
Thumbnail

Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Neprilysin inhibition: news and nuggets

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources